BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10028058)

  • 1. Activation of HIV-1 enhancer sequence by vaccinia virus.
    Adachi A; Oshima Y; Koyama AH
    Int J Mol Med; 1999 Mar; 3(3):311-3. PubMed ID: 10028058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus.
    Popik W; Pitha PM
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9573-7. PubMed ID: 1719535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer.
    West MJ; Karn J
    EMBO J; 1999 Mar; 18(5):1378-86. PubMed ID: 10064603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the human immunodeficiency virus type 1 long terminal repeat by vaccinia virus.
    Stellrecht KA; Sperber K; Pogo BG
    J Virol; 1992 Apr; 66(4):2051-6. PubMed ID: 1548751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
    Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
    Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal in vitro interactions between human herpesvirus-6 and HIV-1 Tat.
    Di Luca D; Secchiero P; Bovenzi P; Rotola A; Caputo A; Monini P; Cassai E
    AIDS; 1991 Sep; 5(9):1095-8. PubMed ID: 1657039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
    Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Epstein-Barr virus BZLF1 gene product activates the human immunodeficiency virus type 1 5' long terminal repeat.
    Mallon R; Borkowski J; Albin R; Pepitoni S; Schwartz J; Kieff E
    J Virol; 1990 Dec; 64(12):6282-5. PubMed ID: 2173793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular factors regulate transactivation of human immunodeficiency virus type 1.
    Barry PA; Pratt-Lowe E; Unger RE; Luciw PA
    J Virol; 1991 Mar; 65(3):1392-9. PubMed ID: 1995949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells.
    Swingler S; Easton A; Morris A
    AIDS Res Hum Retroviruses; 1992 Apr; 8(4):487-93. PubMed ID: 1599755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans-activation of the long terminal repeat of human immunodeficiency virus type 1 by the parvovirus B19 NS1 gene product.
    Sol N; Morinet F; Alizon M; Hazan U
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():2011-4. PubMed ID: 8376975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of HIV type 1 in rabbit cell lines is not limited by deficiencies in tat, rev, or long terminal repeat function.
    Cho S; Kindt TJ; Zhao TM; Sawasdikosol S; Hague BF
    AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1487-93. PubMed ID: 8679293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.
    Scala G; Ruocco MR; Ambrosino C; Mallardo M; Giordano V; Baldassarre F; Dragonetti E; Quinto I; Venuta S
    J Exp Med; 1994 Mar; 179(3):961-71. PubMed ID: 8113688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
    Chen H; He J; Fong S; Wilcox G; Wood C
    J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression.
    Tornesello ML; Buonaguro FM; Beth-Giraldo E; Giraldo G
    Intervirology; 1993; 36(2):57-64. PubMed ID: 8294182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Robinson D; Elliott JF; Chang LJ
    Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transactivation of heterologous promoters by HIV-1 tat.
    Han P; Brown R; Barsoum J
    Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression.
    Lisziewicz J; Rappaport J; Dhar R
    New Biol; 1991 Jan; 3(1):82-9. PubMed ID: 2039768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible gene expression of the human immunodeficiency virus LTR in a replication-incompetent herpes simplex virus vector.
    Warden MP; Weir JP
    Virology; 1996 Dec; 226(1):127-31. PubMed ID: 8941330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.